+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lisdexamfetamine Dimesylate Capsules Market - Global Forecast 2026-2032- Product Image
Lisdexamfetamine Dimesylate Capsules Market - Global Forecast 2026-2032- Product Image
Sale

Lisdexamfetamine Dimesylate Capsules Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134041
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Lisdexamfetamine Dimesylate Capsules Market is projected to reach USD 6.97 Billion in 2026. It is expected to continue growing at a CAGR of 8.47%, reaching USD 11.28 Billion by 2032.

Lisdexamfetamine Dimesylate Capsules: Executive Overview

Lisdexamfetamine dimesylate capsules are prescription central nervous system stimulant medicines primarily used in the management of attention-deficit/hyperactivity disorder (ADHD) and, in some jurisdictions, binge-eating disorder in adults. Their use is shaped by clinical guidelines, controlled-substance regulations, diagnostic practices, supply continuity, and requirements for individualized monitoring. Access and prescribing conditions differ materially across healthcare systems, making regulatory and clinical context central to understanding this market.

Regulatory and Clinical Shifts Reshaping Treatment

The treatment landscape is evolving through greater emphasis on evidence-based ADHD diagnosis, shared decision-making, long-term follow-up, and assessment of cardiovascular, psychiatric, sleep, and substance-use risks. Regulators and healthcare providers continue to focus on appropriate prescribing, diversion prevention, secure dispensing, and controls governing repeat prescriptions. At the same time, telehealth, electronic prescribing, specialist shortages, and medicine-supply disruptions are changing how patients initiate and maintain therapy.

Artificial Intelligence’s Cumulative Impact on Care Pathways

Artificial intelligence can support administrative and clinical workflows by helping identify incomplete records, organize symptom histories, flag potential medication interactions, and improve appointment and refill coordination. Its use requires careful validation because ADHD diagnosis and treatment decisions depend on nuanced clinical assessment rather than automated classification alone. Privacy protection, bias monitoring, explainability, clinician oversight, and compliance with medical-device and health-data rules are essential when AI is applied to prescribing or patient monitoring.

Regional Insights Across Six Healthcare Environments

North America combines established diagnosis and prescribing pathways with strict controlled-substance oversight, insurance variation, and continuing attention to supply availability. Europe is characterized by national and European regulatory frameworks, differing reimbursement policies, and uneven access between specialist and primary-care settings. Asia-Pacific presents diverse clinical capacity, regulatory maturity, and awareness levels, with Japan, Australia, South Korea, China, and India operating under distinct authorization and prescribing systems. Latin America faces variation in controlled-medicine regulation, specialist availability, and public-private access. The Middle East shows substantial differences in registration, import controls, and specialist provision across countries. Africa remains highly heterogeneous, with access influenced by medicine procurement, diagnostic capacity, workforce availability, and controlled-substance governance.

Group-Level Implications for Regulation and Access

ASEAN markets require country-specific consideration because medicine registration, controlled-drug rules, reimbursement, and specialist access differ across member states. BRICS economies span diverse regulatory and healthcare structures, making local authorization, domestic supply resilience, and affordability important operational priorities. The European Union benefits from shared regulatory principles while national prescribing, reimbursement, and dispensing rules remain decisive. G7 countries generally combine mature regulatory systems with strong pharmacovigilance expectations, although access and prescribing pathways vary. GCC markets require attention to centralized or national procurement, import permissions, and controlled-medicine documentation. NATO membership does not create a single pharmaceutical market, so participating countries should be assessed according to their own health and medicines regulations.

Country-Level Priorities for Lisdexamfetamine Access

Australia and Canada emphasize controlled-medicine compliance, specialist or authorized prescriber requirements, and monitored dispensing. Brazil and Mexico operate within evolving regulatory and reimbursement environments where public-private differences affect access. China, India, and Russia require close attention to national registration, controlled-substance policy, and domestic distribution conditions. France, Germany, Italy, Spain, and the United Kingdom apply established medicines oversight while differing in reimbursement, prescribing authority, and care coordination. Japan and South Korea maintain detailed prescription and dispensing controls alongside distinct diagnostic and reimbursement pathways. In the United States, federal controlled-substance requirements interact with state rules, insurance coverage, telehealth policy, and pharmacy availability.

Actionable Priorities for Industry Leaders

Leaders should maintain country-level regulatory maps covering authorization, controlled-substance handling, prescribing, labeling, pharmacovigilance, and promotional restrictions. Supply planning should incorporate secure distribution, inventory visibility, shortage-response procedures, and communication with prescribers and pharmacies. Patient-support initiatives should reinforce appropriate diagnosis, adherence, safe storage, diversion prevention, and timely follow-up without encouraging unsuitable use. Evidence-generation programs should address long-term safety, real-world treatment persistence, health-equity gaps, and outcomes across care settings. AI-enabled tools should be deployed only with documented validation, human review, cybersecurity controls, and transparent data-governance processes.

Research Methodology for the Executive Summary

This summary uses the defined market scope of lisdexamfetamine dimesylate capsules and synthesizes established considerations from medicines regulation, clinical practice, controlled-substance governance, healthcare delivery, pharmacovigilance, and digital-health implementation. The geographic discussion is organized across the specified regions, groups, and countries, with distinctions preserved where regulatory and healthcare conditions differ. No market estimates, market sizing, market shares, forecasts, or company-specific claims are included. Conclusions are framed as evidence-based strategic considerations rather than quantitative market projections.

Conclusion: Responsible Access and Resilient Delivery

The outlook for lisdexamfetamine dimesylate capsules is governed less by a single commercial variable than by the interaction of clinical appropriateness, controlled-medicine regulation, diagnostic capacity, supply reliability, reimbursement, and patient monitoring. Organizations that align local compliance with responsible education, resilient distribution, high-quality evidence, and carefully governed digital tools will be better positioned to support appropriate access. Continuous attention to safety, equity, and jurisdiction-specific requirements should remain central to decision-making.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Lisdexamfetamine Dimesylate Capsules Market, by Dosage Strength
7.1. Introduction
7.2. 10mg
7.3. 20mg
7.4. 30mg
7.5. 40mg
7.6. 50mg
7.7. 60mg
7.8. 70mg
8. Lisdexamfetamine Dimesylate Capsules Market, by Indication
8.1. Introduction
8.2. Attention-Deficit/Hyperactivity Disorder (ADHD)
8.2.1. ADHD in Children & Adolescents
8.2.2. ADHD in Adults
8.3. Binge Eating Disorder
8.3.1. Moderate Binge Eating Disorder
8.3.2. Severe Binge Eating Disorder
8.4. Research & Clinical Trials
9. Lisdexamfetamine Dimesylate Capsules Market, by Patient Age Group
9.1. Introduction
9.2. Adult
9.2.1. Adult (25-64)
9.2.2. Senior (65+)
9.2.3. Young Adult (18-24)
9.3. Pediatric
9.3.1. Adolescent (13-17)
9.3.2. Child (6-12)
10. Lisdexamfetamine Dimesylate Capsules Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Mail Order Pharmacy
10.4. Online Pharmacy
10.5. Retail Pharmacy
10.5.1. Chain Retail
10.5.2. Independent Retail
11. Lisdexamfetamine Dimesylate Capsules Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Lisdexamfetamine Dimesylate Capsules Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Lisdexamfetamine Dimesylate Capsules Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Alkem Laboratories Ltd
15.2. Alvogen
15.3. Amneal Pharmaceuticals, Inc.
15.4. Apotex Corp.
15.5. Aurobindo Pharma Limited
15.6. Granules India Limited
15.7. Granules Pharmaceuticals, Inc.
15.8. Hikma Pharmaceuticals PLC
15.9. Lannett Company, Inc.
15.10. Mallinckrodt Pharmaceuticals Inc.
15.11. Perrigo Company plc
15.12. Rhodes Pharmaceuticals L.P.
15.13. Sandoz International GmbH
15.14. SpecGx LLC
15.15. Sun Pharmaceutical Industries Ltd.
15.16. Takeda Pharmaceuticals
15.17. Teva Pharmaceutical Industries Ltd.
15.18. Viatris Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Lisdexamfetamine Dimesylate Capsules Market, Years Considered for the Study
FIGURE 2. Global Lisdexamfetamine Dimesylate Capsules Market, Research Design
FIGURE 3. Global Lisdexamfetamine Dimesylate Capsules Market, Research Framework
FIGURE 4. Global Lisdexamfetamine Dimesylate Capsules Market, Data Triangulation
FIGURE 5. Global Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2025 vs 2032 (%)
FIGURE 7. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 9. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 11. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Lisdexamfetamine Dimesylate Capsules Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Lisdexamfetamine Dimesylate Capsules Market Segmentation & Coverage
TABLE 2. Global Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
TABLE 3. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 4. Global 10mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global 10mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global 10mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global 20mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global 20mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global 20mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 30mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 30mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 30mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global 40mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global 40mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global 40mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global 50mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global 50mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global 50mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global 60mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global 60mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global 60mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global 70mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global 70mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global 70mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 26. Global Attention-Deficit/Hyperactivity Disorder (ADHD) Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Attention-Deficit/Hyperactivity Disorder (ADHD) Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Attention-Deficit/Hyperactivity Disorder (ADHD) Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global ADHD in Children & Adolescents Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global ADHD in Children & Adolescents Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global ADHD in Children & Adolescents Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global ADHD in Adults Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global ADHD in Adults Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global ADHD in Adults Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Binge Eating Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Binge Eating Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Binge Eating Disorder Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Moderate Binge Eating Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Moderate Binge Eating Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Moderate Binge Eating Disorder Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Severe Binge Eating Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Severe Binge Eating Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Severe Binge Eating Disorder Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Research & Clinical Trials Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Research & Clinical Trials Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Research & Clinical Trials Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 48. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Adult (25-64) Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Adult (25-64) Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Adult (25-64) Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Senior (65+) Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Senior (65+) Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Senior (65+) Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Young Adult (18-24) Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Young Adult (18-24) Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Young Adult (18-24) Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Adolescent (13-17) Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Adolescent (13-17) Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Adolescent (13-17) Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Child (6-12) Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Child (6-12) Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Child (6-12) Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 70. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Mail Order Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Mail Order Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Mail Order Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Chain Retail Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Chain Retail Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Chain Retail Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Independent Retail Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Independent Retail Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Independent Retail Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 99. North America Lisdexamfetamine Dimesylate Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. North America Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 101. North America Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 102. North America Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 103. North America Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 104. North America Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 105. North America Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 106. North America Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 107. North America Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. North America Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 109. Latin America Lisdexamfetamine Dimesylate Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Latin America Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 111. Latin America Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 112. Latin America Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 113. Latin America Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 114. Latin America Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 115. Latin America Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 116. Latin America Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 117. Latin America Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. Latin America Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 119. Europe Lisdexamfetamine Dimesylate Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Europe Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 121. Europe Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 122. Europe Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 123. Europe Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 124. Europe Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 125. Europe Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 126. Europe Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 127. Europe Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. Europe Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 129. Middle East Lisdexamfetamine Dimesylate Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Middle East Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 131. Middle East Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 132. Middle East Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 133. Middle East Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 134. Middle East Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 135. Middle East Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 136. Middle East Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 137. Middle East Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 138. Middle East Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 139. Africa Lisdexamfetamine Dimesylate Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Africa Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 141. Africa Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 142. Africa Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 143. Africa Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 144. Africa Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 145. Africa Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 146. Africa Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 147. Africa Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. Africa Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 149. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. ASEAN Lisdexamfetamine Dimesylate Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. ASEAN Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 152. ASEAN Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 153. ASEAN Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 154. ASEAN Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 155. ASEAN Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 156. ASEAN Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 157. ASEAN Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 158. ASEAN Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. ASEAN Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 160. GCC Lisdexamfetamine Dimesylate Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. GCC Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 162. GCC Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 163. GCC Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 164. GCC Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 165. GCC Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 166. GCC Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 167. GCC Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 168. GCC Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. GCC Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 170. European Union Lisdexamfetamine Dimesylate Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. European Union Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 172. European Union Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 173. European Union Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 174. European Union Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 175. European Union Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 176. European Union Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 177. European Union Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 178. European Union Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. European Union Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 180. BRICS Lisdexamfetamine Dimesylate Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. BRICS Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 182. BRICS Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 183. BRICS Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 184. BRICS Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 185. BRICS Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 186. BRICS Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 187. BRICS Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 188. BRICS Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. BRICS Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 190. G7 Lisdexamfetamine Dimesylate Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. G7 Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 192. G7 Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 193. G7 Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 194. G7 Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 195. G7 Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 196. G7 Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 197. G7 Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 198. G7 Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. G7 Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 200. NATO Lisdexamfetamine Dimesylate Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. NATO Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 202. NATO Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 203. NATO Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 204. NATO Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 205. NATO Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 206. NATO Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 207. NATO Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 208. NATO Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. NATO Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 210. Global Lisdexamfetamine Dimesylate Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 211. United States Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
TABLE 212. United States Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 213. United States Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 214. United States Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 215. United States Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 216. United States Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 217. United States Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 218. United States Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 219. United States Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. United States Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 221. Canada Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
TABLE 222. Canada Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 223. Canada Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 224. Canada Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 225. Canada Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 226. Canada Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 227. Canada Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 228. Canada Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 229. Canada Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. Canada Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 231. Mexico Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
TABLE 232. Mexico Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 233. Mexico Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 234. Mexico Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 235. Mexico Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 236. Mexico Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 237. Mexico Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 238. Mexico Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 239. Mexico Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 240. Mexico Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 241. Brazil Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
TABLE 242. Brazil Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 243. Brazil Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 244. Brazil Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 245. Brazil Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 246. Brazil Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 247. Brazil Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 248. Brazil Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 249. Brazil Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 250. Brazil Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 251. United Kingdom Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
TABLE 252. United Kingdom Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 253. United Kingdom Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 254. United Kingdom Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 255. United Kingdom Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 256. United Kingdom Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 257. United Kingdom Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 258. United Kingdom Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 259. United Kingdom Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. United Kingdom Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 261. Germany Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
TABLE 262. Germany Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 263. Germany Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 264. Germany Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 265. Germany Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 266. Germany Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 267. Germany Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 268. Germany Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 269. Germany Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. Germany Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 271. France Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
TABLE 272. France Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 273. France Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 274. France Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 275. France Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 276. France Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 277. France Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 278. France Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 279. France Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 280. France Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 281. Russia Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
TABLE 282. Russia Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 283. Russia Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 284. Russia Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 285. Russia Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 286. Russia Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 287. Russia Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 288. Russia Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 289. Russia Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 290. Russia Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 291. Italy Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
TABLE 292. Italy Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 293. Italy Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 294. Italy Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 295. Italy Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 296. Italy Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 297. Italy Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 298. Italy Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 299. Italy Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 300. Italy Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 301. Spain Lisdexamfetamine Dimesylate Capsules Market Size, 2017-2032 (USD Million)
TABLE 302. Spain Lisdexamfetamine Dimesylate Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 303. Spain Lisdexamfetamine Dimesylate Capsules Market Size, by Indication, 2017-2032 (USD Million)
TABLE 304. Spain Lisdexamfetamine Dimesylate Capsules Market Size, by Attention-Deficit/Hyperactivity Disorder (ADHD), 2017-2032 (USD Million)
TABLE 305. Spain Lisdexamfetamine Dimesylate Capsules Market Size, by Binge Eating Disorder, 2017-2032 (USD Million)
TABLE 306. Spain Lisdexamfetamine Dimesylate Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 307. Spain Lisdexamfetamine Dimesylate Capsules Market Size, by Adult, 2017-2032 (USD Million)
TABLE 308. Spain Lisdexamfetamine Dimesylate Capsules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 309. Spain Lisdexamfetamine Dimesylate Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 310. Spain Lisdexamfetamine Dimesylate Capsules Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 311. China Lisdexamfetamine Dimesylate Capsules Market Size, 2017

Companies Mentioned

  • Alkem Laboratories Ltd
  • Alvogen
  • Amneal Pharmaceuticals, Inc.
  • Apotex Corp.
  • Aurobindo Pharma Limited
  • Granules India Limited
  • Granules Pharmaceuticals, Inc.
  • Hikma Pharmaceuticals PLC
  • Lannett Company, Inc.
  • Mallinckrodt Pharmaceuticals Inc.
  • Perrigo Company plc
  • Rhodes Pharmaceuticals L.P.
  • Sandoz International GmbH
  • SpecGx LLC
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Related Topics

Related Reports

Lisdexamfetamine Dimesylate Generics Market - Global Forecast 2026-2032 - Product Image

Lisdexamfetamine Dimesylate Generics Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Central Nervous System Stimulant Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis by Poduct Type (Lisdexamfetamine, Dextroamphetamine, Methylphenidate HCl, Other Product Types), Application - Product Image

Central Nervous System Stimulant Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis by Poduct Type (Lisdexamfetamine, Dextroamphetamine, Methylphenidate HCl, Other Product Types), Application

  • Report
  • 160 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Attention Deficit Hyperactivity Disorder - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 140 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder Market Outlook 2026-2034: Market Share and Growth Analysis by Drug Type, Age Group, Distribution Channel - Product Image

Attention Deficit Hyperactivity Disorder Market Outlook 2026-2034: Market Share and Growth Analysis by Drug Type, Age Group, Distribution Channel

  • Report
  • 160 Pages
  • Global
From
ADHD Drugs Market Insights, Analysis and Forecast 2026-2031 - Product Image

ADHD Drugs Market Insights, Analysis and Forecast 2026-2031

  • Report
  • 125 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.